TY  - JOUR

T1  - The DANTE trial protocol: a randomised phase III trial to evaluate the Duration of ANti-PD-1 monoclonal antibody Treatment in patients with metastatic mElanoma

JO  - BMC Cancer

UR  - https://eprints.whiterose.ac.uk/176339/

PY  - 2021/07/01

AU  - Coen O

AU  - Corrie P

AU  - Marshall H

AU  - Plummer R

AU  - Ottensmeier C

AU  - Hook J

AU  - Bell S

AU  - Sagoo GS

AU  - Meads D

AU  - Bestall J

AU  - Velikova G et al

ED  - 

DO  - DOI: 10.1186/s12885-021-08509-w

PB  - Springer Science and Business Media LLC

VL  - 21

IS  - 1

Y2  - 2024/09/19

ER  -